Your browser doesn't support javascript.
loading
Relapse of Palmoplantar Pustulosis Following COVID-19 Vaccination.
Katsuie, Shiho; Nakamura, Kenta; Ogawa, Eisaku; Arakura, Fuyuko; Okuyama, Ryuhei.
Afiliação
  • Katsuie S; Department of Dermatology, Shinshu University School of Medicine, Matsumoto, JPN.
  • Nakamura K; Department of Dermatology, Shinshu University School of Medicine, Matsumoto, JPN.
  • Ogawa E; Department of Dermatology, Shinshu University School of Medicine, Matsumoto, JPN.
  • Arakura F; Division of Dermatology, National Hospital Organization Matsumoto Medical Center, Matsumoto, JPN.
  • Okuyama R; Department of Dermatology, Shinshu University School of Medicine, Matsumoto, JPN.
Cureus ; 14(8): e28604, 2022 Aug.
Article em En | MEDLINE | ID: mdl-36185929
Palmoplantar pustulosis (PPP) is a rare chronic pustular condition that affects the palms and soles. Smoking and focal infections and dental metal allergies are risk factors for PPP development. Here we report a case of a 60-year-old woman who experienced a relapse of PPP after receiving the COMIRNATY vaccine against COVID-19. The patient relapsed after being in remission for seven years. This article shows the possible implications of COVID-19 vaccination related to the relapse of previous diseases and stresses the importance of careful observation of post-vaccination occurrences of skin eruptions, especially in patients having a history of PPP.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article